Details for Patent: 8,618,172
✉ Email this page to a colleague
Which drugs does patent 8,618,172 protect, and when does it expire?
Patent 8,618,172 protects TEKTURNA HCT and is included in one NDA.
This patent has thirty-two patent family members in twenty-five countries.
Summary for Patent: 8,618,172
Title: | Galenical formulations of organic compounds |
Abstract: | The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, a therapeutically effective amount of HCTZ and a hydrophilic filler selected from the group a carbohydrate or combinations thereof, e.g. sugars, sugar alcohols and starches or combinations of these. |
Inventor(s): | Willmann; Matthias (Basel, CH) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 12/304,244 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,618,172 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 8,618,172
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Noden Pharma | TEKTURNA HCT | aliskiren hemifumarate; hydrochlorothiazide | TABLET;ORAL | 022107-001 | Jan 18, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Noden Pharma | TEKTURNA HCT | aliskiren hemifumarate; hydrochlorothiazide | TABLET;ORAL | 022107-002 | Jan 18, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Noden Pharma | TEKTURNA HCT | aliskiren hemifumarate; hydrochlorothiazide | TABLET;ORAL | 022107-003 | Jan 18, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Noden Pharma | TEKTURNA HCT | aliskiren hemifumarate; hydrochlorothiazide | TABLET;ORAL | 022107-004 | Jan 18, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,618,172
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0612540.5 | Jun 23, 2006 |
PCT Information | |||
PCT Filed | June 21, 2007 | PCT Application Number: | PCT/EP2007/005476 |
PCT Publication Date: | December 27, 2007 | PCT Publication Number: | WO2007/147596 |
International Family Members for US Patent 8,618,172
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 061565 | ⤷ Sign Up | |||
Australia | 2007263261 | ⤷ Sign Up | |||
Brazil | PI0713338 | ⤷ Sign Up | |||
Canada | 2654872 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |